Wilmington, Delaware, United States, June 24, 2022 (GLOBE NEWSWIRE) -- Recent insights on the chronic pelvic pain treatment market highlight the trend of expanding array of therapies and medications including chiropractic care, acupuncture, biofeedback therapy, and cognitive behavioral therapy. Widespread adoption of pain relief medications continues to fuel sales of chronic pelvic pain treatment market. The global chronic pelvic pain treatment market is projected to surpass value of US$ 8 Bn by the end of the forecast period of 2022–2031.
The commercialization of medications and/or cause-directed therapies has allowed each leading company to grow market share for chronic pelvic pain treatment products. Advances in diagnosis of chronic pelvic pain are reinforcing the market value of the chronic pelvic pain treatment products. The expansion of the chronic pelvic pain treatment market is thus being propelled by the availability of effective management strategies.
The demand for OTC pain relievers, NSAIDs, and many non-opioid pain medications is expected to propel revenue streams for pharmaceutical companies in the chronic pelvic pain treatment market. Growing awareness about the range of treatment and management options available for chronic pelvic pain (CPP) is likely to catalyze lucrative opportunities in the near future.
Request Brochure of Chronic Pelvic Pain Treatment Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84850
Key Findings of Chronic Pelvic Pain Treatment Market Study
- Massive Adoption of OTC Medications Propelling Revenue Growth: The use of pain relief medications, both OTC and prescribed, has spurred the revenue prospects in the chronic pelvic pain treatment market. Of note, the chronic pelvic pain treatment market has witnessed stable revenue opportunities from high preference for OTC medications. The demand has been bolstered by accessibility in retail pharmacies & drug stores. The study found that the medications segment held a major share of the global chronic pelvic pain treatment market with about 70% in 2021.
- Rise in Demand for Various Therapies Enrich Prospects: Extensive R&D on the structural and idiopathic causes of CPP and increased understanding of the etiology have expanded the options of therapies for patients, thus enriching the prospects of the chronic pelvic pain treatment market. However non-surgical options especially pain management drugs are preferred over other treatments. Furthermore, increasing emphasis on patient-centered care is boosting profitable opportunities.
Request for Analysis of COVID-19 Impact on Chronic Pelvic Pain Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84850
Chronic Pelvic Pain Treatment Market: Key Drivers
- Prevalence of chronic pelvic pain especially among women of all ages is a key driver of the market. Multidisciplinary patient-centered care approaches are expanding the canvas for players in the chronic pelvic pain treatment market.
- Growing acceptance of generic drugs for chronic pelvic pain is expected to boost the revenue streams. Focus toward increasing the diagnosis and boosting access to adequate care will propel the future growth trajectories.
Get Exclusive PDF Sample Copy of Chronic Pelvic Pain Treatment Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84850
Chronic Pelvic Pain Treatment Market: Regional Growth Dynamics
- North America held a major share of the global chronic pelvic pain treatment market in 2021. The growth has been underpinned by rising incidence of the pain condition. Especially among women, the prevalence is high in the U.S.
- Europe is another lucrative market and in 2021 it held a market share of about 31%. Wide awareness about the treatments including medications has catalyzed prospects of the regional market.
Chronic Pelvic Pain Treatment Market: Key Players
Some of the prominent companies in the chronic pelvic pain treatment market are Perrigo Company plc., Medtronic, Mayne Pharma Group Limited, MAST PAK SURGICAL CORP, Intuitive Surgical, Hospiinz, GSK plc., Becton, Dickinson and Company, and Bayer AG.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84850
Chronic Pelvic Pain Treatment Market Segmentation
- Technology
- Medications
- Pain Relievers
- Hormone Treatments
- Antibiotics
- Antidepressants
- Surgery
- Laparoscopic Surgery
- Hysterectomy
- Others
- Medications
- Distribution Channel
- Retail Pharmacies & Drug stores
- E-commerce
- Others
Regions
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Countries
- U.S.
- Canada
- Germany
- U.K.
- France
- Spain
- Italy
- Japan
- China
- India
- Australia & New Zealand
- Brazil
- Mexico
- GCC Countries
- South Africa
More Trending Reports by Transparency Market Research –
Pelvic Floor Electrical Stimulation Devices Market: The rise in prevalence of urinary incontinence and other pelvic floor disorders, and favorable medical reimbursement policies are the major factors boosting the growth of the global pelvic floor electrical stimulation devices market.
Solitary Fibrous Tumor Treatment Market: Increase in per capita disposable income is encouraging people to spend more on healthcare, which, in turn, propels the global solitary fibrous tumor treatment market
Amblyopia Treatment Market: The amblyopia treatment market is expected to grow at a CAGR of 3.7% during the forecast period. Atropine sulfate eye drops are popular for the treatment of amblyopia and other eye conditions, including cycloplegia.
Lyme Disease Treatment Market: Increase in pet ownership, surge in awareness & adoption of veterinary care, and rise in healthcare expenditure on animals are anticipated to drive the global Lyme disease treatment market from 2021 to 2031.
Sepsis Treatment Market: Growth of the sepsis treatment market can be attributed to increase in patient population with infectious diseases such as COVID-19 and acute kidney injury; rise in investment by pharmaceutical and biotechnology companies in drug discovery; and surge in launch of new products for the treatment of sepsis.
Recto-vaginal Fistula Treatment Market: The rise in prevalence of Crohn’s disease resulting in the occurrence of recto-vaginal fistula is driving the global recto-vaginal fistula treatment market.
Acute Agitation and Aggression Treatment Market: The acute agitation and aggression treatment market is projected to cross the value of US$ 7.09 Bn by 2031. Acute agitation is a frequent occurrence in both inpatient and outpatient psychiatric settings.
Acute Viral Rhinosinusitis Treatment Market: The acute viral rhinosinusitis treatment market is projected to surpass US$ 3.16 Bn by 2031. However, it has been found that in many cases, antibiotics do not prevent the complications of bacterial acute rhinosinusitis (ABRS).
About Us
Transparency Market Research is a global market intelligence company providing market analysis reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: http://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
